Starling OncologySTLN
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 34 institutions reported holding Starling Oncology Inc. (STLN) in their 13F filings, down 5 from Q2 2024. 1 opened new positions and 5 sold out. The largest holders were FMR LLC ($1.6M), Deerfield Management Company, L.P. ($1.1M) and Tiff Advisory Services, LLC ($861K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Starling Oncology Inc.
- Filed as
- THE ONCOLOGY INSTITUTE INC (Q3 2024)
- CUSIP
- 68236X100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6K |
| Exits | 5 | $65K |
All 13F filers, Q2 2024 → Q3 2024: 2,897,030 shares bought and 504,493 shares sold, net +2,392,537 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| FMR LLC | 0.00% | Reduce -0.0% | 4,749,900 | $1.6M |
| Deerfield Management Company, L.P. | 0.02% | No change | 3,360,052 | $1.1M |
| Tiff Advisory Services, LLC | 0.29% | Add +85.6% | 2,632,885 | $861K |
| Cincinnati Insurance Co. | 0.01% | Add +190.8% | 2,034,045 | $665K |
| Kent Lake PR LLC | 0.26% | — | 2,000,000 | $654K |
| Vanguard Group Inc. | 0.00% | No change | 1,783,454 | $583K |
| Balyasny Asset Management L.P. | 0.00% | No change | 1,725,562 | $564K |
| Boston Financial Mangement LLC | 0.01% | Reduce -3.2% | 2,679 | $253K |
| Geode Capital Management, LLC | 0.00% | Add +5.5% | 379,981 | $124K |
| FourWorld Capital Management LLC | 0.08% | No change | 257,000 | $84K |
| BlackRock, Inc. | 0.00% | — | 252,940 | $83K |
| FreeGulliver LLC | 0.04% | No change | 188,169 | $62K |
| Renaissance Technologies | 0.00% | Reduce -49.9% | 170,000 | $56K |
| Quattro Financial Advisors LLC | 0.01% | Add +190.8% | 162,724 | $53K |
| Bank of New York Mellon Corp | 0.00% | Add +177.7% | 125,141 | $41K |
| State Street Corp. | 0.00% | No change | 101,300 | $33K |
| Saba Capital Management, L.P. | 0.00% | No change | 94,264 | $31K |
| Citadel Advisors | 0.00% | Reduce -66.1% | 91,337 | $30K |
| HighTower Advisors, LLC | 0.00% | Add +190.8% | 81,362 | $27K |
| Lee Financial Co | 0.00% | Add +190.8% | 81,362 | $27K |
| Fielder Capital Group LLC | 0.01% | No change | 70,192 | $23K |
| Northern Trust Corp. | 0.00% | No change | 64,902 | $21K |
| Susquehanna International Group, LLP | 0.00% | Add +10.4% | 34,411 | $11K |
| Morgan Stanley | 0.00% | Add +3.6% | 30,392 | $10K |
| XTX Topco Ltd | 0.00% | Add +119.2% | 25,109 | $8K |
| Cresset Asset Management, LLC | 0.00% | No change | 18,300 | $6K |
| Jane Street Group, LLC | 0.00% | Reduce -43.4% | 17,890 | $6K |
| Two Sigma Securities, LLC | 0.00% | New | 16,997 | $6K |
| Qube Research & Technologies Ltd | 0.00% | No change | 15,642 | $5K |
| AMG National Trust Bank | 0.00% | No change | 10,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -10.5% | 8,799 | $3K |
| Bank of America Corp. | 0.00% | Add +1.4% | 2,707 | $882 |
| JPMorgan Chase & Co. | 0.00% | Add +0.6% | 171 | $56 |
| Citigroup Inc. | 0.00% | Reduce -37.5% | 25 | $8 |
"% of holder's portfolio" is STLN's weight in each manager's 13F, not the share of Starling Oncology Inc. the manager owns.